Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

HIV infection is associated with higher mortality in individuals presenting with reduced level of consciousness to a referral hospital in Uganda.
Global Health and Neuroepidemiology
P9 - Poster Session 9 (12:00 PM-1:00 PM)
13-005

We sought to elucidate the clinical characteristics, mortality and predictors of mortality among patients admitted with reduced level of consciousness to a tertiary hospital in Uganda.

The clinical epidemiology of patients with reduced level of consciousness (LOC) in Sub-Saharan Africa (SSA) is unknown.
We secondarily analyzed data from 336 patients prospectively admitted with reduced LOC, obtaining baseline clinical characteristics, labs, and 30-day follow-up. We also prospectively recorded the investigations or treatments that clinicians deemed to be crucial for patient care, but were not available (unmet need). We summarized patient characteristics, computed mortality rates and used logistic regression to determine predictors of 30-day mortality.  

The mean age (SD) in the cohort was 50.8 (21.7) years and 97/336(28.8%) were HIV positive (HIV+). The median (IQR) Full Outline of Unresponsiveness (FOUR) score was 14 (11 -15). The most common diseases associated with reduced LOC were metabolic encephalopathy 106/336 (31.5%) and central nervous system infections 93/336 (27.7%). An unmet need in clinical care such as lack of respiratory support, electroencephalography, or a crucial medication occurred in 150/336 (44.6%).  In-hospital complications such as respiratory failure, status epilepticus or worsening LOC occurred in 147/289 (50.9%) of individuals. Thirty-day mortality in the total cohort was 148/329 (45.0%) and this was significantly higher among HIV+ individuals compared to HIV-; 55/97(56.7%) vs. 93/233 (39.9%), p=0.005. Predictors of mortality (aOR (95%CI), p value) included admission FOUR score <12 (3.95 (2.21, 7.04), <.0001), anemia (1.70 (1.02, 2.83), 0.0424), respiratory distress (1.68 (1.00, 2.77), p =0.0490), HIV infection (1.93 (1.11, 3.36), p=0.0198) and presence of an unmet clinical need (1.66 (1.01, 2.73), p=0.0468).  

Reduced LOC in Uganda is associated with high mortality rates, with worse outcomes in HIV infected individuals. Provision of intensive care services and other diagnostic studies may mitigate the poor outcomes observed in this population.

 

Authors/Disclosures
Amir A. Mbonde, MD
PRESENTER
Dr. Mbonde has nothing to disclose.
Amir A. Mbonde, MD Dr. Mbonde has nothing to disclose.
Bart Demaerschalk, MD, MSc, FRCPC, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Nan Zhang Nan Zhang has nothing to disclose.
Richard Butterfield No disclosure on file
Cumara B. O'Carroll, MD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. O'Carroll has nothing to disclose.